Literature DB >> 2918304

Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.

J Sirviö1, R Kutvonen, H Soininen, P Hartikainen, P J Riekkinen.   

Abstract

In patients with probable Alzheimer's disease and in controls, acetyl- and butyrylcholinesterase activities were studied in cerebrospinal fluid (CSF) and plasma, and acetylcholinesterase activity of erythrocytes was determined. In addition, the molecular forms of acetylcholinesterase were measured in CSF. Severely demented patients had significantly lower acetylcholinesterase (p less than 0.01) and butyrylcholinesterase (p less than 0.05) activities in CSF than the controls had, but the activities of these enzymes in plasma and erythrocytes were within the same range in both groups. Acetylcholinesterase and butyrylcholinesterase activities in the CSF of mildly demented patients did not differ from control values. The ratio of the intermediate molecular form of acetylcholinesterase to the light molecular form of the enzyme did not differ significantly between patients with Alzheimer's disease and controls. According to our results, AChE levels were lower in the CSF of severely demented patients, but both light and intermediate molecular forms were affected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918304     DOI: 10.1007/BF01677425

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  31 in total

1.  Dementia without cholinergic deficit.

Authors:  P J Riekkinen; H Soininen; J Sirviö; K Reinikainen; E L Helkala; L Paljärvi
Journal:  Gerontology       Date:  1987       Impact factor: 5.140

2.  Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.

Authors:  G M Bisso; C Masullo; H Michalek; M C Silveri; M Pocchiari
Journal:  Life Sci       Date:  1986-02-10       Impact factor: 5.037

3.  Presynaptic cholinergic dysfunction in patients with dementia.

Authors:  N R Sims; D M Bowen; S J Allen; C C Smith; D Neary; D J Thomas; A N Davison
Journal:  J Neurochem       Date:  1983-02       Impact factor: 5.372

4.  Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis.

Authors:  B W Festoff; H L Fernandez
Journal:  Muscle Nerve       Date:  1981 Jan-Feb       Impact factor: 3.217

5.  CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF.

Authors:  S Lal; P L Wood; M E Kiely; P Etienne; S Gauthier; J Stratford; R M Ford; D Dastoor; N P Nair
Journal:  Neurobiol Aging       Date:  1984       Impact factor: 4.673

6.  Acetylcholinesterase activity in ventricular and cisternal CSF of dogs: effect of chlorpromazine.

Authors:  S R Bareggi; E Giacobini
Journal:  J Neurosci Res       Date:  1978       Impact factor: 4.164

7.  Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.

Authors:  R Elble; E Giacobini; G F Scarsella
Journal:  Arch Neurol       Date:  1987-04

8.  Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.

Authors:  J R Atack; E K Perry; J R Bonham; J M Candy; R H Perry
Journal:  J Neurochem       Date:  1986-07       Impact factor: 5.372

9.  Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.

Authors:  J Sirviö; H S Soininen; R Kutvonen; J M Hyttinen; E L Helkala; P J Riekkinen
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

Review 10.  Alzheimer's disease and related dementias: selective involvement of specific neuronal systems.

Authors:  P J Whitehouse; R G Struble; J C Hedreen; A W Clark; D L Price
Journal:  CRC Crit Rev Clin Neurobiol       Date:  1985
View more
  4 in total

1.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Reassessing blood acetylcholinesterase in dementia.

Authors:  Pengcheng Han
Journal:  J Neurosci Rural Pract       Date:  2015-01

3.  Altered levels of acetylcholinesterase in Alzheimer plasma.

Authors:  María-Salud García-Ayllón; Iolanda Riba-Llena; Carol Serra-Basante; Jordi Alom; Rathnam Boopathy; Javier Sáez-Valero
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

Review 4.  Salivary biomarkers for the diagnosis and monitoring of neurological diseases.

Authors:  Raymond Farah; Hayat Haraty; Ziad Salame; Youssef Fares; David M Ojcius; Najwane Said Sadier
Journal:  Biomed J       Date:  2018-05-10       Impact factor: 4.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.